Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study

European Journal of Cancer

Volumn 44, Issue 16, 2008, Pages 2470-2476

  Capelle, L G ^a   de Vries, A C ^a   Looman, C W N ^a   Casparie, M K ^b   Boot, H ^c   Meijer, G A ^d   Kuipers, E J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Stichting PALGA   (Netherlands)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epidemiology; Gastric cancer; MALT lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR; STOMACH LYMPHOMA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 54249154133     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.07.005     Document Type: Article

References (52)

1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 52 (1992) 6735-6740
2. Farinha P., and Gascoyne R.D. Helicobacter pylori and MALT lymphoma. Gastroenterology 128 (2005) 1579-1605
3. Fox J.G., and Wang T.C. Inflammation, atrophy, and gastric cancer. J Clin Invest 117 (2007) 60-69
4. Ferlay JBF, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon: IARC Press; 2004.
5. de Vries A.C., Meijer G.A., Looman C.W., et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 56 (2007) 1665-1670
6. Post P.N., Kuipers E.J., and Meijer G.A. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 23 (2006) 1587-1593
7. Isaacson P., and Wright D.H. Malignant lymphoma of mucosa-associated lymphoid tissue a distinctive type of B-cell lymphoma. Cancer 52 (1983) 1410-1416
8. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338 (1991) 1175-1176
9. Gurney K.A., Cartwright R.A., and Gilman E.A. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 79 (1999) 1929-1934
10. Stolte M., Bayerdorffer E., Morgner A., et al. Helicobacter and gastric MALT lymphoma. Gut 50 Suppl. 3 (2002) III19-24
11. Bayerdorffer E., Miehlke S., Neubauer A., et al. Gastric MALT-lymphoma and Helicobacter pylori infection. Aliment Pharmacol Ther 11 Suppl. 1 (1997) 89-94
12. Severson R.K., and Davis S. Increasing incidence of primary gastric lymphoma. Cancer 66 (1990) 1283-1287
13. Lamarque D., Levy M., Chaumette M.T., et al. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma. Am J Gastroenterol 101 (2006) 1886-1893
14. Wundisch T., Thiede C., Morgner A., et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23 (2005) 8018-8024
15. Morgner A., Miehlke S., Stolte M., et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 7 (2001) 248-253
16. Hamaloglu E., Topaloglu S., Ozdemir A., et al. Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature. World J Gastroenterol 12 (2006) 3564-3574
17. Goteri G., Ranaldi R., Rezai B., et al. Synchronous mucosa-associated lymphoid tissue lymphoma and adenocarcinoma of the stomach. Am J Surg Pathol 21 (1997) 505-509
18. Arista-Nasr J., Jimenez-Rosas F., Uribe-Uribe N., et al. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas. Am J Gastroenterol 96 (2001) 1746-1750
19. Bayerdorffer E., Neubauer A., Rudolph B., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345 (1995) 1591-1594
20. Au W.Y., Gascoyne R.D., Le N., et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 10 (1999) 317-321
21. Fischbach W., Goebeler M.E., Ruskone-Fourmestraux A., et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56 (2007) 1685-1687
22. Casparie M., Tiebosch A.T., Burger G., et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29 (2007) 19-24
23. Van den Brandt P.A., Schouten L.J., Goldbohm R.A., et al. Development of a record linkage protocol for use in the Dutch cancer registry for epidemiological research. Int J Epidemiol 19 (1990) 553-558
24. Cote R.A., and Robboy S. Progress in medical information management. Systematized nomenclature of medicine (SNOMED). JAMA 243 (1980) 756-762
25. Statistics Netherlands. 2007.www.cbs.nl.
26. Doglioni C., Wotherspoon A.C., Moschini A., et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339 (1992) 834-835
27. Ullrich A., Fischbach W., and Blettner M. Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann Oncol 13 (2002) 1120-1127
28. Loffeld R.J., and van der Putten A.B. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol 38 (2003) 938-941
29. Wotherspoon A.C., Doglioni C., Diss T.C., et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342 (1993) 575-577
30. Brands F., Monig S.P., and Raab M. Treatment and prognosis of gastric lymphoma. Eur J Surg 163 (1997) 803-813
31. Koch P., Probst A., Berdel W.E., et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 23 (2005) 7050-7059
32. Fischbach W., Dragosics B., Kolve-Goebeler M.E., et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 119 (2000) 1191-1202
33. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
34. Loffeld R.J., Stobberingh E., van Spreeuwel J.P., et al. The prevalence of anti-Helicobacter (Campylobacter) pylori antibodies in patients and healthy blood donors. J Med Microbiol 32 (1990) 105-109
35. van Vuuren A.J.d.M.R., van Driel H.F., et al. Seroprevalence of Helicobacter pylori in two asymptomatic Dutch populations. Gastroenterology 130 Suppl. 2 (2006) T1895
36. Nakamura S., Aoyagi K., Iwanaga S., et al. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients. Cancer 79 (1997) 1077-1085
37. Chan A.O., Chu K.M., Yuen S.T., et al. Synchronous gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in association with Helicobacter pylori infection: comparing reported cases between the East and West. Am J Gastroenterol 96 (2001) 1922-1924
38. Zucca E., Pinotti G., Roggero E., et al. High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 6 (1995) 726-728
39. Huang J.Q., Zheng G.F., Sumanac K., et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125 (2003) 1636-1644
40. Kuipers E.J. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 13 Suppl. 1 (1999) 3-11
41. de Vries A.C., van Grieken N.C., Looman C.W., et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 134 (2008) 945-952
42. Neubauer A., Thiede C., Morgner A., et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89 (1997) 1350-1355
43. Copie-Bergman C., Gaulard P., Lavergne-Slove A., et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 52 (2003) 1656
44. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
45. Du M.Q., and Atherton J.C. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 55 (2006) 886-893
46. Ye H., Liu H., Attygalle A., et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 102 (2003) 1012-1018
47. Inagaki H., Nakamura T., Li C., et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 28 (2004) 1560-1567
48. Nakamura T., Seto M., Tajika M., et al. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol 103 (2008) 62-70
49. Copie-Bergman C., Locher C., Levy M., et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?. Ann Oncol 16 (2005) 1232-1236
50. Boot H., and de Jong D. Diagnosis, treatment decisions, and follow up in primary gastric lymphoma. Gut 51 (2002) 621-622
51. El-Zimaity H.M., and Graham D.Y. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 30 (1999) 72-77
52. Zauber N.P., and Berman E.L. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathologic study of 12 patients. Cancer 82 (1998) 226-227